Through cross-sectional magnetic resonance Through cross-sectional magnetic resonance imaging studies, it is now well established imaging studies, it is now well established that brain volume reductions are present that brain volume reductions are present in schizophrenia (Wright in schizophrenia (Wright et al et al, 2000) . Were , 2000) . Were these reductions to reflect the disease prothese reductions to reflect the disease process, one would expect them to mimic cess, one would expect them to mimic the clinical course and to be related to the clinical course and to be related to outcome. A cross-sectional magnetic resooutcome. A cross-sectional magnetic resonance imaging study (van Haren nance imaging study (van Haren et al et al, , 2003 ) examined brain volume change as a 2003) examined brain volume change as a predictor of outcome in recent-onset schizopredictor of outcome in recent-onset schizophrenia, but did not find any associations phrenia, but did not find any associations between the static baseline brain volume between the static baseline brain volume measurements and clinical and functional measurements and clinical and functional outcomes after 2 years. As brain volume outcomes after 2 years. As brain volume reductions have been shown to be proreductions have been shown to be progressive (Cahn gressive (Cahn et al et al, 2002; Lieberman , 2002; Lieberman et et al al, 2005; Woods , 2005; Woods et al et al, 2005) , dynamic , 2005), dynamic brain volume changes, using two magnetic brain volume changes, using two magnetic resonance measurements, might be more resonance measurements, might be more informative in relation to clinical and funcinformative in relation to clinical and functional outcome. In a similar study, we tional outcome. In a similar study, we examined 34 people with first-episode examined 34 people with first-episode schizophrenia at baseline and after 1 year schizophrenia at baseline and after 1 year and compared them with 36 healthy people. and compared them with 36 healthy people.
An accelerated decline in total brain volume An accelerated decline in total brain volume and in grey matter volume and an increase and in grey matter volume and an increase in lateral ventricle volume were found in in lateral ventricle volume were found in patients compared with healthy individuals patients compared with healthy individuals (Cahn (Cahn et al et al, 2002) . These progressive , 2002). These progressive changes were not associated with sympchanges were not associated with symptoms, but did predict functional outcome toms, but did predict functional outcome 2 years after the initial assessment. Thus, in 2 years after the initial assessment. Thus, in contrast to static brain volumes, dynamic contrast to static brain volumes, dynamic brain measurements could be more useful brain measurements could be more useful in predicting outcome in schizophrenia. in predicting outcome in schizophrenia. As the clinical course of schizophrenia reaches As the clinical course of schizophrenia reaches a plateau after about 5 years following the a plateau after about 5 years following the initial treatment (Davidson & McGlashan, initial treatment (Davidson & McGlashan, 1997) , the present study clinically re-1997), the present study clinically reexamined the same individuals 5 years after examined the same individuals 5 years after the initial evaluation, using various outcome the initial evaluation, using various outcome measures. It was hypothesised that early brain measures. It was hypothesised that early brain volume changes in schizophrenia predict the volume changes in schizophrenia predict the longer-term outcome of the illness. longer-term outcome of the illness. Magnetic resonance images were acMagnetic resonance images were acquired on a 1.5 Philips NT scanner and quired on a 1.5 Philips NT scanner and obtained at inclusion (T0) and after 1 year obtained at inclusion (T0) and after 1 year (T1). In-house developed software was (T1). In-house developed software was used to measure mean (s. To assess whether dynamic brain volume To assess whether dynamic brain volume changes in the first year predict the 5-year changes in the first year predict the 5-year clinical and functional outcome, linear reclinical and functional outcome, linear regression analyses were performed with the gression analyses were performed with the unstandardised regression coefficient ( unstandardised regression coefficient (b b) re-) representing the outcome score per millilitre presenting the outcome score per millilitre volume change. Brain volume change (T0 volume change. Brain volume change (T0 to T1) of the various brain structures entered to T1) of the various brain structures entered the analyses as predictor variables, with age the analyses as predictor variables, with age and intracranial volume as covariates. As and intracranial volume as covariates. As progressive brain volume change might have progressive brain volume change might have commenced before T0, baseline measures of commenced before T0, baseline measures of the brain structures also entered the analyses the brain structures also entered the analyses as covariates. The various clinical and funcas covariates. The various clinical and functional outcome scores obtained at T5 entered tional outcome scores obtained at T5 entered the analyses as dependent variables sepathe analyses as dependent variables separately. Since clinical outcome might be varirately. Since clinical outcome might be variable initially but could stabilise over time, able initially but could stabilise over time, the same analyses were done with changes the same analyses were done with changes in PANSS scores (T1 to T5) as dependent in PANSS scores (T1 to T5) as dependent variables. To assess whether clinical decline variables. To assess whether clinical decline is progressive, paired-sample is progressive, paired-sample t t-tests were -tests were performed with PANSS scores (T1 to T5) performed with PANSS scores (T1 to T5) and CAN scores (T2 to T5) as paired and CAN scores (T2 to T5) as paired variables. variables. (Fig. 1a) , a lower GAF 0.002) (Fig. 1a) , a lower GAF score ( score (b b¼0.40, 0.40, t t¼2.79, 2.79, P P¼ 0.01) and a lesser 0.01) and a lesser likelihood of living independently ( likelihood of living independently (b b¼7 70.01, 0.01, t t¼7 73.94, 3.94, P P¼0.001) (Fig. 1b) at T5. 0.001) (Fig. 1b) at T5. A greater white matter volume increase in A greater white matter volume increase in the first year predicted higher positive sympthe first year predicted higher positive symptom score ( tom score (b b¼0.09, 0.09, t t¼2.29, 2.29, P P¼0.03) at T5. 0.03) at T5.
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S H O R T R E P O R T S H O R T R E P O R T
A greater lateral ventricle volume A greater lateral ventricle volume increase in the first year predicted a greater increase in the first year predicted a greater number of met and unmet needs ( number of met and unmet needs (b b¼1.47, 1.47, t t¼2.82, 2.82, P P¼0.009) (Fig. 1c) as measured 0.009) (Fig. 1c) 
DISCUSSION DISCUSSION
This study found that early progressive This study found that early progressive brain volume changes in the first year can brain volume changes in the first year can predict the 5-year outcome of schizopredict the 5-year outcome of schizophrenia. Those patients who had the largest phrenia. Those patients who had the largest decrease in grey matter in the first year had decrease in grey matter in the first year had the highest negative symptom scores and the highest negative symptom scores and were less likely to live independently 5 were less likely to live independently 5 years after the first evaluation. Thus, it years after the first evaluation. Thus, it appears that early dynamic brain changes appears that early dynamic brain changes are not only associated with symptomatic are not only associated with symptomatic outcome but also with functional outcome. outcome but also with functional outcome. Furthermore, these findings suggest that Furthermore, these findings suggest that brain changes in the early stages of schizobrain changes in the early stages of schizophrenia are related to the disease process phrenia are related to the disease process and are clinically relevant in determining and are clinically relevant in determining prognosis, and they emphasise the prognosis, and they emphasise the importance of early intervention in the importance of early intervention in the treatment of schizophrenia, aiming to slow treatment of schizophrenia, aiming to slow down or stop progressive brain volume loss. down or stop progressive brain volume loss. This view is strengthened by another This view is strengthened by another longitudinal magnetic resonance study that longitudinal magnetic resonance study that examined dynamic brain volume changes in examined dynamic brain volume changes in people at very high risk of developing people at very high risk of developing schizophrenia (Pantelis schizophrenia (Pantelis et al et al, 2003) . This , 2003) . This study reported progressive grey matter study reported progressive grey matter decrease in very-high-risk individuals who decrease in very-high-risk individuals who developed a psychotic illness within 12 developed a psychotic illness within 12 months. None the less, whether these early months. None the less, whether these early progressive brain volume changes in progressive brain volume changes in prodromal and first-episode schizophrenia prodromal and first-episode schizophrenia are caused by the disease itself or are a are caused by the disease itself or are a consequence of the disease (and its consequence of the disease (and its treatment) still remains unanswered. The treatment) still remains unanswered. The treatment of schizophrenia should focus treatment of schizophrenia should focus on slowing this early progressive brain loss, on slowing this early progressive brain loss, with the goal of affecting the clinical course with the goal of affecting the clinical course favourably. favourably. 3 8 2 3 8 2 
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